Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization

Raja.M

Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization - Ooty JSS AHER (JSSCP OOTY) 2022 - 200

Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization

APA

Raja.M, Suresh Kumar.R, . (2022). Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization. Ooty: JSS AHER (JSSCP OOTY).

Chicago

Raja.M, Suresh Kumar.R, . 2022. Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization. Ooty: JSS AHER (JSSCP OOTY).

Harvard

MLA

Raja.M, Suresh Kumar.R, . Carbon Nanotubes loaded with T30 Oligonucleotide and Ibrutinib for the Effective management of prostate Carcinoma Formulation Design, Development and In Vitro Characterization. Ooty: JSS AHER (JSSCP OOTY). 2022.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core ISBD MARC (non-Unicode/MARC-8) MARCXML MODS (XML) RIS MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard)
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC